|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.30 USD | -1.45% |
|
+8.48% | +14.04% |
| 07-30 | CONMED Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Raised | MT |
| 07-30 | CONMED Corporation, Q2 2026 Earnings Call, Jul 29, 2026 |
Company Valuation: CONMED Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,146 | 2,702 | 3,368 | 2,114 | 1,257 | 1,387 | - | - |
| Change | - | -34.83% | 24.64% | -37.22% | -40.53% | 10.3% | - | - |
| Enterprise Value (EV) 1 | 4,810 | 3,728 | 4,317 | 2,995 | 2,051 | 2,128 | 2,025 | 1,906 |
| Change | - | -22.5% | 15.81% | -30.62% | -31.52% | 3.74% | -4.86% | -5.87% |
| P/E | 73.1x | -33.1x | 53.7x | 16.1x | 26.9x | 11.9x | 10.3x | 9.67x |
| PBR | 5.26x | 3.57x | 4.04x | 2.2x | 1.1x | 1.22x | 1.07x | 0.93x |
| PEG | - | 0x | -0x | 0x | -0.4x | 0x | 0.7x | 1.45x |
| Capitalization / Revenue | 4.1x | 2.58x | 2.71x | 1.62x | 0.91x | 1.02x | 0.97x | 0.92x |
| EV / Revenue | 4.76x | 3.57x | 3.47x | 2.29x | 1.49x | 1.56x | 1.41x | 1.26x |
| EV / EBITDA | 24.4x | 19.8x | 18.3x | 11.3x | 7.44x | 7.6x | 6.86x | 6.07x |
| EV / EBIT | 33.6x | 28.4x | 24.8x | 14.8x | 9.5x | 9.94x | 8.93x | 7.6x |
| EV / FCF | 49.6x | 322x | 40.6x | 19.5x | 13.6x | 9.94x | 12.3x | 11.4x |
| FCF Yield | 2.01% | 0.31% | 2.46% | 5.14% | 7.36% | 10.1% | 8.13% | 8.76% |
| Dividend per Share 2 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | - | - | - |
| Rate of return | 0.56% | 0.9% | 0.73% | 1.17% | 1.97% | - | - | - |
| EPS 2 | 1.94 | -2.68 | 2.04 | 4.25 | 1.51 | 3.88 | 4.49 | 4.79 |
| Distribution rate | 41.2% | -29.9% | 39.2% | 18.8% | 53% | - | - | - |
| Net sales 1 | 1,011 | 1,045 | 1,245 | 1,307 | 1,375 | 1,366 | 1,434 | 1,511 |
| EBITDA 1 | 197.2 | 188.7 | 235.4 | 265.6 | 275.9 | 280 | 295 | 314 |
| EBIT 1 | 143.3 | 131.3 | 174.4 | 202.8 | 216 | 214 | 226.6 | 250.9 |
| Net income 1 | 62.54 | -80.58 | 64.46 | 132.4 | 47.06 | 116.7 | 135 | 142.6 |
| Net Debt 1 | 663.8 | 1,026 | 949.6 | 881.3 | 794.1 | 741.5 | 637.9 | 519.2 |
| Reference price 2 | 141.76 | 88.64 | 109.51 | 68.44 | 40.60 | 46.30 | 46.30 | 46.30 |
| Nbr of stocks (in thousands) | 29,247 | 30,482 | 30,752 | 30,891 | 30,968 | 29,951 | - | - |
| Announcement Date | 1/26/22 A | 2/2/23 A | 1/31/24 A | 2/5/25 A | 1/28/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 11.93x | 1.56x | 7.6x | -.--% | 1.39B | |
| 30.26x | 4.12x | 15.99x | 2.44% | 183B | |
| 19.35x | 3.38x | 11.9x | 3.48% | 109B | |
| 17.32x | 0.19x | 12.22x | 0.76% | 60.57B | |
| 30.52x | 7.55x | 19.29x | 1.35% | 51.8B | |
| 36.06x | 3.22x | 10.97x | 2.37% | 45.64B | |
| 37.66x | 1.37x | 12.1x | 0.21% | 33.22B | |
| 33.77x | 5.97x | 18.75x | -.--% | 31.49B | |
| 39.76x | 6.96x | 24.98x | 0.26% | 24B | |
| 24.32x | 3.69x | 12.93x | 1.14% | 22.26B | |
| Average | 28.09x | 3.80x | 14.67x | 1.2% | 56.26B | |
| Weighted average by Cap. | 28.00x | 3.83x | 14.85x | 1.94% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CNMD Stock
- Valuation CONMED Corporation
Select your edition
All financial news and data tailored to specific country editions
